Patients with RHI/TES who were Aβ[ −] did not differ from controls on visuospatial testing or plasma GFAP, but had higher plasma NfL than controls and higher plasma IL-6 than both controls and patients with AD. Here, GFAP is linked to Alzheimer disease.